We provide you with 20 years of free, institutional-grade data for ALLK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALLK. Explore the full financial landscape of ALLK stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-05-09 | 1564824 | ALLK | 10-Q | Url |
| 2024-03-14 | 1564824 | ALLK | 10-K | Url |
| 2023-11-13 | 1564824 | ALLK | 10-Q | Url |
| 2023-08-09 | 1564824 | ALLK | 10-Q | Url |
| 2023-05-09 | 1564824 | ALLK | 10-Q | Url |
| 2023-03-06 | 1564824 | ALLK | 10-K | Url |
| 2022-11-07 | 1564824 | ALLK | 10-Q | Url |
| 2022-08-04 | 1564824 | ALLK | 10-Q | Url |
| 2022-05-06 | 1564824 | ALLK | 10-Q | Url |
| 2022-03-01 | 1564824 | ALLK | 10-K | Url |
| 2021-11-08 | 1564824 | ALLK | 10-Q | Url |
| 2021-08-09 | 1564824 | ALLK | 10-Q | Url |
| 2021-05-10 | 1564824 | ALLK | 10-Q | Url |
| 2021-03-01 | 1564824 | ALLK | 10-K | Url |
| 2020-11-09 | 1564824 | ALLK | 10-Q | Url |
| 2020-08-10 | 1564824 | ALLK | 10-Q | Url |
| 2020-05-11 | 1564824 | ALLK | 10-Q | Url |
| 2020-02-25 | 1564824 | ALLK | 10-K | Url |
| 2019-11-12 | 1564824 | ALLK | 10-Q | Url |
| 2019-08-05 | 1564824 | ALLK | 10-Q | Url |
| 2019-05-08 | 1564824 | ALLK | 10-Q | Url |
| 2019-03-14 | 1564824 | ALLK | 10-K | Url |
| 2018-11-08 | 1564824 | ALLK | 10-Q | Url |
| 2018-08-29 | 1564824 | ALLK | 10-Q | Url |
| 2018-06-22 | 1564824 | ALLK | S-1 | Url |
Allakos Inc(NASDAQ:ALLK) 
Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic es...
Website: http://www.allakos.com
Founded: 2012
Full Time Employees: 114
CEO: Robert D. Alexander Ph.D.
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ALLK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.